Megan C. Brown, MD, describes results from an emergency department–based initiative to improve the diagnostic accuracy of testing for von Willebrand disease in adolescents with heavy menstrual bleeding.
Recent Articles
FDA Committee Votes to Withdraw Two Accelerated Approvals of Cancer Treatments
The U.S. Food and Drug Administration’s (FDA’s) Oncologic Drugs Advisory Committee (ODAC) recommended withdrawing two of six accelerated approvals of cancer treatments that it...
Pipette Tip Shortage Hinders Scientific Work Worldwide
An ongoing pipette tip shortage caused by the COVID-19 pandemic, blackouts in Texas, and a manufacturing plant fire is hindering scientific work around the...
Will the FDA Crack Down on Clinical Trial Reporting Noncompliance?
The U.S. Food and Drug Administration (FDA) has issued its first notice of noncompliance to Acceleron Pharma for failing to submit clinical trial results...
FDA Committee Meets to Reconsider Accelerated Approvals of Cancer Drugs
On April 27, the U.S. Food and Drug Administration’s (FDA’s) Oncologic Drugs Advisory Committee began its first meeting in a decade to reconsider accelerated...
Are Survivors of Childhood Lymphomas At Increased Risk of Cognitive Impairment?
Researchers from the Yale Cancer Center report that the systemic therapies received by survivors of childhood cancers may impact their long-term cognitive outcomes, with...
Current Issue
May 2021 Volume 7 Issue 6
This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.